Press "Enter" to skip to content

Merck wins U.S. FDA approval for expanded use of antibiotic

The approval is based on the treatment’s late-stage trial results, which showed that Merck’s drug, Zerbaxa, was as effective as another antibacterial drug.

Original source: https://health.economictimes.indiatimes.com/news/pharma/merck-wins-u-s-fda-approval-for-expanded-use-of-antibiotic/69641844?utm_source=RSS&utm_medium=ETRSS

Also Read:   AstraZeneca vaccine's promise now drawn into question